Description

LL-37 (CAP-18) 5 mg is a physician-formulated peptide developed to support targeted physiological pathways with precision. It interacts with key signaling mechanisms that influence metabolic balance, cellular repair, immune regulation, or performance capacity depending on clinical use. Through its activity, it helps reinforce healthy functional patterns within the body.

• Supports regulated biological responses.
• Helps maintain physiological stability.
• Integrates well into structured clinical protocols.

Clinicians often incorporate LL-37 (CAP-18) 5 mg as part of individualized treatment strategies designed around patient-specific goals.